FDA Inspection 1169446 - Aurobindo Pharma Limited - May 10, 2022

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Aurobindo Pharma Limited

Record Details

This FDA Inspection record concerns Aurobindo Pharma Limited, with an inspection on May 10, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Aurobindo Pharma Limited
Inspection Date: May 10, 2022
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · b9201ac7-5ec4-46dd-8aaf-7304c3c93094

Violation Codes6

21 CFR 211.100(a)21 CFR 211.166(a)21 CFR 211.18821 CFR 211.19221 CFR 211.6321 CFR 211.68(b)

Full citation text and observation details available on the Dashboard.